Sentiss is an international niche pharmaceutical company that develops and markets a range of ophthalmic, inhalation, ENT and specialty products. Their range of products cover dry-eye, glaucoma, mydriatics, anti-bacterial, anti-inflammatory, anti-infective, ocular nutritional supplements, local anaesthetics, ocular lubricants, solutions and suspensions for nebulization. The company is focused on developing niche products that create value globally for all its stakeholders.